Istradefylline
RxNorm 2199015
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2199015 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: istradefylline.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Istradefylline
(Atom ID: 11446565)
PTPrescribable
Designated preferred name (PT):
Istradefylline
(Atom ID: 11825611)
FNPrescribable
Full form of descriptor (FN):
Istradefylline (substance)
(Atom ID: 11825612)
PTPrescribable
Designated preferred name (PT):
Istradefylline-containing product
(Atom ID: 11825615)
FNPrescribable
Full form of descriptor (FN):
Product containing istradefylline (medicinal product)
(Atom ID: 11826323)
Patient Education
Istradefylline
Istradefylline is used along with the combination of levodopa and carbidopa (Duopa, Rytary, Sinemet, others) to treat "off" episodes (times of difficulty moving, walking, and speaking that may happen as medication wears off or at random) in people with Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Istradefylline is in a class of medications called adenosine receptor antagonists. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.